NEWS CENTER

On December 13^th, our company welcomed the visit of Mr. Xie Shaolin, CEO of FeiYueBio, and conducted in-depth exchanges and investigations on the production process, product quality, marketing and other aspects of our company.

FeiYueBio has always made outstanding achievements in the field of biotechnology, and as the older predecessors of our industry, they have a wide experience and professional team in the field of life sciences. They have been focusing on R&D and production in the biopharmaceuticals and life sciences, and they are committed to providing high-quality biologics, antibodies, proteins, cell media and other biological reagents to meet the needs of scientific research, drug development and clinical diagnosis.

In this exchange, Mr. Xie Shaolin, CEO of FeiYueBio introduced to us the development history, technical strength and product advantages of their company. And we Reed Biotech also shared with them our latest achievements and development directions in the field of biologics, antibody screening and automated experiments for mutual exchange and learning.

Mr. Xie Shaolin given a highly approvals on our achievements in automated production. He also expressed appreciation for our investment and achievements in automated high-throughput screening of antibody pairs and the realization of a fully automated laboratory. He believes that the introduction and application of this technology provides a more efficient and accurate tool for laboratory research, which greatly improves the efficiency of laboratory work and the reliability of experimental data.

Mr. Xie Shaolin’s visit not only enhanced the cooperation and exchange between Reed Biotech and FeiYueBio, but also put forward valuable suggestions and opinions on our technology and laboratory management. We will cherish this rare exchange opportunity, continue to work hard and innovate, and contribute more to the development of the field of biotechnology.

We do believe that with the joint efforts of both parties, the future of our industry will be more hopeful and opportunities. We are looking forward to cooperating with FeiYueBio to write a new chapter in the development of the industry and make greater contributions to human health and scientific research!